News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
simplywall.st Market update
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
UFP Technologies (NASDAQ: UFPT) has filed a Form 144 to register the planned sale of 2,349 shares of common stock through Merrill Lynch on or after August 14, 2026. The shares have an aggregate market value of $625,145.67 and represent a small fraction of …
An insider at UFP Technologies (UFPT) has filed a Form 144 to sell 1,000 shares of common stock through Merrill Lynch, with an anticipated sale date of August 13, 2026, on NASDAQ. The filing indicates the seller previously received stock awards for compensation in …
The article analyzes Ufp Technologies Inc. (NASDAQ: UFPT), indicating a near-term neutral sentiment but mid and long-term strength. It highlights compelling upside potential with no resistance levels above the current price. The analysis includes AI-generated institutional trading strategies for position trading, momentum breakouts, and …
UFP Technologies director Joseph John Hassett has filed an amended Form 4 to correct an administrative error in his previously reported share holdings. The amendment clarifies that his correct beneficial ownership of Common Stock, $.01 Par Value, following a reported transaction was 2,602 shares, …
UFP Technologies, Inc. (UFPT) is presented as an appealing investment opportunity in the medical devices sector, boasting a $2.52 billion market cap and strong revenue growth of 15.10%. The company specializes in designing and manufacturing solutions for various medical devices, including advanced wound care …
UFP Technologies Executive Chairman Jeffrey R. Bailly reported the indirect sale of 13,011 shares of Common Stock from a trust on August 10, 2026. The sales occurred in multiple open-market transactions at weighted average prices ranging from $315.53 to $317.27 per share, totaling approximately …
The article reports that an officer at UFP Technologies (UFPT.US) sold common stock worth US$5 million. This transaction indicates a significant insider sale at the company.
UFP Technologies Executive Chairman R. Jeffrey Bailly sold 15,695 shares of company stock for a total transaction value of $4,997,050. This insider transaction comes as UFPT shares are trading at $323.4, down 1.12%. The article also provides an overview of UFP Technologies's financial health, …
Jeffrey R. Bailly, Executive Chairman of UFP Technologies (UFPT), reported the sale of 15,695 shares of common stock on August 6-7, 2026, through indirect holdings in a trust. The sales occurred at weighted-average prices ranging from approximately $315.06 to $320.05 per share. After these …
R. Jeffrey Bailly, Executive Chairman of UFP Technologies Inc. (NASDAQ:UFPT), recently sold approximately $4.997 million worth of company shares in early August. These transactions occurred on August 6 and 7, 2026, involving 15,695 shares sold at prices between $315.06 and $320.05 per share. The …
UFP Technologies (NASDAQ:UFPT) Chairman R. Jeffrey Bailly sold 5,013 shares of the company's stock on August 7th, 2026, for approximately $1.59 million, reducing his direct ownership by 27.81%. This follows another sale of 10,682 shares on August 6th. The company's stock traded near its …
R. Jeffrey Bailly, Chairman of UFP Technologies (NASDAQ:UFPT), recently sold 10,682 shares for $3.40 million, reducing his stake by 37.21%, and an additional 5,013 shares for $1.59 million. Despite these sales, UFP Technologies stock rose to $325, near its 52-week high, following a strong …
UFP Technologies (UFPT) reported strong Q2 2026 results with sales of US$173.96 million and net income of US$20.85 million, leading to a 23.2% stock increase. The company's first-half performance shows increased profitability and sales, supporting its investment narrative focused on operational efficiency and strategic …
Royal Bank of Canada reduced its stake in UFP Technologies (NASDAQ:UFPT) by 12.5% in the first quarter, selling 11,343 shares and retaining 79,179 shares valued at $15.3 million. Despite this, UFP Technologies reported strong quarterly earnings of $2.92 EPS and revenue of $173.96 million, …
Janus Henderson Group PLC significantly reduced its stake in UFP Technologies, Inc. (NASDAQ:UFPT) by 75.5% in the first quarter, now holding 19,436 shares valued at $3.76 million. Despite this, other institutional investors have increased their holdings, with institutional investors collectively owning 87.28% of the …
UFP Technologies (NASDAQ:UFPT) was upgraded to a "Buy" rating by Wall Street Zen, though its overall analyst rating remains "Hold" due to Weiss Ratings only slightly increasing its score. The company recently reported strong quarterly earnings, beating both EPS and revenue estimates. Despite recent …
UFP Technologies reported strong financial results for Q2 2026, with net sales increasing by 15.1% to $174.0 million and diluted EPS reaching $2.68. The growth was primarily driven by its medical sub-markets, leading to an improved gross margin of 29.3%. Despite these gains, the …
UFP Technologies Inc. (UFPT) filed a Form 144 with the SEC on August 6, 2026, indicating a proposed sale of 1100 shares of common stock by an unnamed individual. The shares, acquired via a stock award from the issuer on March 3, 2025, have …
UFP Technologies Vice President Jason Holt sold 1,100 shares of the company's common stock at $317 per share on August 6, 2026. This open market transaction totaled $349,000. Following the sale, Holt directly owns 7,878 shares of UFPT common stock.
UFP Technologies, Inc. (NASDAQ:UFPT) surpassed analyst expectations for its second-quarter results, with revenues reaching US$174m and statutory earnings per share exceeding predictions by 16%. Following these strong results, analysts have updated their forecasts, moderately increasing revenue and EPS predictions for 2026 and raising the …
Dimensional Fund Advisors LP increased its stake in UFP Technologies (NASDAQ:UFPT) by 6.6% in the first quarter, now owning 179,973 shares valued at approximately $34.84 million. This move comes as UFP Technologies reported strong Q2 results, exceeding analyst estimates with adjusted EPS of $2.92 …
UFP Technologies (UFPT) reported record Q2 2026 results with sales of $173.96 million and net income of $20.85 million. Despite a strong stock performance, the company trades at a P/E of 30.2x, which is a premium to the medical equipment industry average. However, a …
UFP Technologies (UFPT) stock is up significantly today after the company reported strong second-quarter earnings, exceeding Wall Street expectations. The healthcare product manufacturer saw sales grow by 15% and adjusted EPS by 17%, driven by its core medtech unit and strategic acquisitions, despite flat …
UFP Technologies (NASDAQ:UFPT) reached a new 52-week high after reporting stronger-than-expected quarterly earnings, with EPS of $2.92 against a $2.31 consensus and revenue of $173.96 million compared to $159.38 million expected. Despite the stock surge, analysts maintain a "Hold" rating with an average price …
(RTTNews) - UFP Technologies, Inc. (UFPT) revealed earnings for its second quarter that Increases, from last year The company's bottom line came in at $20.85 million, or $2.68 per share. This compares with $17.18 million, or $2.21 per share, last year. Excluding items, UFP …
UFP Technologies (NASDAQ:UFPT) recently announced its quarterly earnings, surpassing analyst expectations with an EPS of $2.92 against a consensus of $2.31, and revenue of $173.96 million over an estimated $159.38 million. Following the strong results, the company's shares rose 5% to $267.53, giving it …
UFP Technologies (UFPT) reported a record second quarter, with net sales increasing 15.1% to $174.0 million and net income rising 21.4% to $20.9 million. The company's GAAP diluted EPS was $2.68, and adjusted diluted EPS was $2.92. Insider trading activity for UFPT shows three …
UFP Technologies reported record second-quarter 2026 results with net sales of $174.0 million, a 15.1% increase year-over-year, and net income up 21.4% to $20.9 million. The company achieved strong MedTech growth and improved gross margins, driven by solid execution and strategic investments in its …
UFP Technologies Inc. reported record second-quarter 2026 results with net income of $20.9 million, a 21.4% increase, and net sales of $174.0 million, up 15.1% year-over-year. The company's MedTech business showed strong growth, with its top five customers growing by 14.7% and the rest …
UFP Technologies, Inc. (UFPT) announced its Q2 2026 revenue reached $174.0 million, surpassing the FactSet estimate of $159.4 million. The company also reported Q2 adjusted EPS of $2.92 per share, exceeding the FactSet estimate of $2.31. UFP Technologies is a designer and custom manufacturer …
UFP Technologies's (NASDAQ:UFPT) Q2 CY2026: Strong Sales, Stock Soars Medical products company UFP Technologies (NASDAQ:UFPT) reported Q2 CY2026 results exceeding the market's revenue expectations , with sales up 15.1% year on year to $174 million. Its non-GAAP profit of $2.92 per share was 14.2% …
Search by ticker symbol or company name and select a result to open its chart.